Geostrategic Media Political Commentary, Analysis, Security, Defense
Lisdey Pedraza
On 7 March 2026, Donald Trump convened a select group of Latin American and Caribbean leaders at his own golf resort in Doral, Florida, under the banner of the “Shield of the Americas”. The optics were deliberate: strength, unity, urgency. The setting was telling in a different way. This was not a neutral diplomatic venue or a multilateral institution, but a private Trump property, channelling summit fees directly into the president’s pocket. The name evokes protection and resolve.
The substance, on closer inspection, evokes something far older and far less heroic: five decades of militarised drug war policy that has, in every country and every era it has touched, produced more violence, more corruption, more dead civilians, and more drugs. The Shield of the Americas is not a policy innovation. It is a continuation of a long-standing paradigm in US hemispheric strategy: the same assumptions, the same tools, and the same contradictions, repackaged for a new political moment.
Background: What Drove Trump to Create This
The emergence of the Shield is best understood as a convergence of political, geopolitical, and strategic pressures rather than any genuine reassessment of what works. Domestically, drug consumption in the US has shifted but not diminished. The opioid crisis, the proliferation of synthetic drugs, and the persistence of cocaine markets continue to generate political demand for visible action.
Trump had spent his campaign years demonising migrants as cartel vectors, designating Mexican criminal organisations as foreign terrorist organisations, and threatening military strikes across the southern border. The summit at Doral was the institutional crystallisation of that rhetoric, a way of giving operational form to the Monroe Doctrine revived, the hemisphere reimagined as a US security perimeter.
Internationally, the initiative reflects a more competitive geopolitical environment, particularly with China’s expanding economic presence across Latin America. In this context, the Shield operates simultaneously as a counter-narcotics framework and a mechanism for reasserting regional influence. Participation skewed heavily toward right-leaning administrations willing to align with Washington’s security agenda: Argentina’s Javier Milei, Ecuador’s Daniel Noboa, El Salvador’s Nayib Bukele, and Chile’s president-elect José Antonio Kast among them.
This selective inclusion is not incidental. It reinforces a bloc politics logic in which counter-narcotics cooperation becomes a vehicle for broader political alignment. The Shield is as much about political ordering in the hemisphere as it is about drug interdiction.
The official objectives, as released in the summit communiqué, were strikingly thin: expand multilateral security cooperation, conduct “whole of government” efforts on border security and counter-narcotics, advance peace through strength, and combat narco-terrorism. This amounted to a half-page declaration and four general points, noble in aspiration but entirely devoid of mechanism, funding commitments, or any acknowledgement of the root causes of the trade in poverty, weak states, and corruption.
Seventeen Latin American countries signed on to the Americas Counter Cartel Coalition, with the explicit promise of US military assistance in targeting cartel infrastructure. What it conspicuously did not offer was resources for the cash-strapped armed forces of its members, nor any strategy that departed from the supply-side orthodoxy that has governed US drug policy since 1971.
A Genealogy of Failure: Previous US Initiatives
To understand the Shield, it must be situated within the lineage of US-led counter-narcotics efforts. The framework begins with Richard Nixon, whose 1971 declaration of drugs as “public enemy number one” institutionalised a prohibitionist and enforcement-driven model, a framing that his own aide John Ehrlichman later admitted was designed to target certain communities and the anti-war left rather than to address any genuine public health crisis. From that foundational dishonesty, every subsequent administration built upward.
Under Ronald Reagan, counter-narcotics policy became entangled with Cold War strategy, particularly in Central America. The lines between combating drugs and supporting geopolitical allies blurred profoundly: the CIA’s covert Contra supply networks relied on the very cocaine trade Reagan was publicly condemning, and in South Asia, agency operatives were alleged to have facilitated opium smuggling from Afghanistan to fund the anti-Soviet resistance. The War on Drugs and the Cold War were never separate projects. They were always the same project.
George H.W. Bush’s use of direct military intervention, most notably the dispatch of 30,000 Marines to Panama to arrest Manuel Noriega on drug trafficking charges established a further precedent. Noriega had been a CIA asset when Bush directed the agency. With the Cold War ending, he had outlived his usefulness. The pattern was immediately legible: drug charges as a geopolitical weapon, applied selectively against former allies who had become inconvenient.
Clinton’s Plan Colombia institutionalised large-scale security assistance, aerial eradication, and private military contractors: DynCorp providing pilots, planes, and chemicals for fumigation campaigns that destroyed food crops, poisoned waterways, and exposed rural communities to toxic chemicals, whilst coca cultivation continued.
The post-9/11 period under George W. Bush further fused counter-narcotics with counterterrorism. The Mérida Initiative extended this model into Mexico, sending homicide rates soaring as cartel structures splintered into more numerous and more violent factions rather than fewer.
Obama’s drug policy chief announced he would abandon the language of “war on drugs”, and Secretary of State Clinton publicly acknowledged that US demand was driving the trade and that existing policies had failed. Yet on the ground, Plan Colombia and Mérida continued uninterrupted.
Biden attempted a domestic pivot toward harm reduction for the opioid crisis whilst maintaining militarised operations abroad, a split that was structurally revealing: decriminalisation at home for largely suburban opioid sufferers, military operations abroad across the Global South. The Shield of the Americas represents a continuation of this trajectory rather than any departure from it.
Afghanistan: The Drug War’s Greatest Global Failure
The clearest proof that this model does not work lies not in Latin America but in Afghanistan, where the US spent nearly nine billion dollars on counter-narcotics between 2001 and 2021. Over two hundred airstrikes targeted suspected drug laboratories, many of which turned out to be empty mud-walled compounds — whilst senior Pentagon officials were left asking why F-22 fighters costing over £28,000 per flight hour were being deployed against rudimentary opium stills.
At its peak, Afghanistan supplied over ninety per cent of the world’s illicit heroin and more land was devoted to opium cultivation there than to coca across all of Latin America combined.
Eradication campaigns in Taliban-controlled areas actively backfired, consolidating cultivation in insurgent hands and strengthening Taliban revenues. Between 2010 and 2014, poppy cultivation across the country nearly doubled even as USAID invested millions attempting to shift farmers toward wheat, a measure farmers circumvented simply by relocating their poppy fields to adjacent provinces.
When US forces departed in 2021, the trade was larger than when they arrived. No supply-side suppression measure has ever produced lasting results in an active conflict zone. Washington spent twenty years learning this lesson and has drawn no conclusions from it.
Global Parallels: The Same Pattern, Different Postcode
The US is not alone in having pursued militarised anti-trafficking strategies to no lasting effect. The pattern replicates itself across continents.
West Africa illustrates the spillover costs most starkly. As enforcement intensified along traditional trafficking routes in the early 2000s, the region became a key transit hub for cocaine destined for Europe. Weak institutional capacity and existing vulnerabilities made countries including Guinea-Bissau, Sierra Leone, Senegal, and Cabo Verde susceptible to criminal penetration. European-backed interdiction efforts pushed traffickers toward these smaller, less-monitored ports rather than eliminating flows.
Criminal networks adapted, routes diversified, and cocaine volumes reaching Europe increased. The UNODC described the dynamic plainly: consumption in European cities was financing disaster across West Africa, adding organised criminality to poverty, unemployment, and disease. European policy responded not by addressing its own demand but by hardening African borders, exporting the costs of northern consumption to some of the world’s most fragile states.
Within Europe’s own ports, the results were equally instructive. Improved interdiction at Antwerp and Rotterdam pushed traffickers toward chemical concealment, narco-submarines, and smaller entry points elsewhere on the continent.
Cocaine use across Western and Central Europe rose by eighty per cent between 2011 and 2024. Drug laboratories refining coca into cocaine began appearing across the continent, and criminal organisations from Albania, the Balkans, Italy, and Morocco now operate in direct alliance with Latin American traffickers.
Europe is not a passive market. Its ports, logistics systems, and criminal networks constitute active infrastructure for the global trade it claims to be suppressing. More enforcement produced more sophisticated crime, not less.
The one genuine counter-model emerged from within Europe. Portugal decriminalised all drug use in 2001, reorienting policy around public health rather than punishment. By 2018, the number of heroin addicts had fallen from one hundred thousand to twenty-five thousand, drug-related deaths were the lowest in Western Europe, and HIV infections from drug use had declined by ninety per cent, at a cost of less than ten dollars per citizen per year against the trillion dollars the US spent over the same period pursuing the opposite approach.
Portugal’s model has real limits: it decriminalised possession without regulating supply, leaving production and distribution in criminal hands. Its own architects warned that decriminalisation without broader social and economic reform was a half-measure at best. But as a demonstration that the alternative to militarisation exists and produces measurable results, it has not been credibly rebutted.
The Politics of Exclusion: Who Was Left Out and Why It Matters
One of the Shield’s most significant structural weaknesses lies in who was not in the room at Doral. Brazil, Mexico, and Colombia: the three largest economies in Latin America, each confronting organised crime at enormous scale, each possessing sophisticated law enforcement institutions and capable military forces were absent.
Mexico is the primary corridor for drugs entering the US. Colombia remains the world’s largest cocaine producer. Brazil is the largest domestic market in South America and a critical transshipment node. Without these three countries, the coalition is a discussion about hemispheric security from which the hemisphere’s most consequential actors are excluded.
The exclusion was ideological rather than strategic. The coalition assembled along lines of political affinity, not operational relevance. Latin America’s history is littered with multilateral organisations built on ideological solidarity rather than durable institutional consensus: UNASUR, ALBA, CELAC.
Most have collapsed or become dormant as the political pendulum swings. Any coalition assembled on partisan closeness rather than shared institutional architecture is guaranteed a rotating membership and no continuity across electoral cycles.
Several participating coalition members face severe internal challenges related to corruption, institutional weakness, and documented links between state actors and organised crime. The administration pardoned Juan Orlando Hernández, the former Honduran president who was serving a forty-year US prison sentence for drug trafficking whilst arresting the sitting president of Venezuela on the same grounds.
The selectivity is structural, not accidental. The drug war has always been a framework for managing which criminal networks are useful to US interests, not for eliminating the trade as such.
The absent countries represent precisely the alternative approaches the Shield refuses to consider. Colombia under Gustavo Petro has pursued negotiated settlements with armed groups over bombardment. Mexico has repeatedly resisted US military operations on its territory. Brazil under Lula has been cautious about any initiative that replicates patterns of US military dominance in the region. Their absence is not incidental, it reflects the fact that the countries most capable of contributing meaningfully to regional security are precisely those unwilling to accept the terms on which the Shield was offered.
How Successful Will This Be?
Bluntly: it will not meaningfully reduce drug trafficking, and there is no credible analytical basis for expecting it to. The coalition’s founding document contains no new resources, no agreed operational procedures, no monitoring mechanisms, and no strategy that diverges from the supply-side enforcement model that has failed continuously since the early 1970s.
The balloon effect: sustained pressure in one location displacing production and trafficking to others, has been documented in every theatre from the Andes to the Sahel to the Hindu Kush. There is no reason to expect different results from a thinner, more ideologically constrained coalition with less institutional depth than its predecessors.
The economic logic of the trade further complicates enforcement. High demand, combined with prohibition, creates powerful and persistent incentives for market entry. As long as those conditions remain unchanged, supply will adapt to enforcement pressure.
Disruptions may alter routes or shift actors; they do not eliminate the underlying activity. Decades of eradication, interdiction, and militarisation have not produced sustained declines in production or availability anywhere in the world. The Shield offers no mechanism for addressing demand, no strategy for economic alternatives to cultivation, and no plan for building the institutional capacity in member states upon which any durable counter-narcotics effort depends.
Symbolism Over Substance
What the Shield of the Americas does accomplish, quite effectively, is political performance. It projects US dominance in the hemisphere, rewards aligned governments with the legitimacy of a White House photo opportunity, and creates a legal and rhetorical framework for military operations that might otherwise require congressional authorisation.
Operation Southern Spear, extending from a Caribbean naval buildup to joint bombardment on the Colombian-Ecuadorian border, with a death toll from extrajudicial maritime strikes already exceeding one hundred and fifty people, is the operational reality the summit’s branding exists to cover.
Defence Secretary Hegseth’s remarks at the summit, which opened with a quotation from Andrew Jackson and rallied the assembled leaders as “Christian nations under God” against “radical narco-comunism and narco-tyranny”, revealed the ideological purpose beneath the counter-narcotics framing.
The language is not new: Reagan’s counterinsurgency doctrine systematically fused leftist politics with drug criminality to delegitimise governments that resisted US economic influence. The Shield updates that tradition. The enemy is not the cartel. It is any political project in Mexico, Colombia, Bolivia, or elsewhere that challenges the terms of hemispheric subordination.
The secondary agenda was made equally visible in Kristi Noem’s remarks, which called on coalition members to reverse Chinese influence in their business, technology, and infrastructure. China is now Latin America’s largest lender and trading partner.
Even the Shield’s most committed members: Milei’s Argentina, Bukele’s El Salvador, depend on Chinese commerce and investment for basic economic function. The drug war is the cover story. The deeper contest is with Beijing, and it is one the Shield, as currently constituted, is wholly unequipped to prosecute.
The initiative also reflects a broader tendency in US policy to repackage existing strategies under new labels. By presenting the Shield as a novel response, it obscures the fundamental continuity of the underlying approach and delays the critical reassessment that the evidence demands.
The language of “shielding” suggests defence against external threats, yet the dynamics of drug trafficking are not external in any simple sense. They are co-produced by demand in the Global North, prohibition, and global economic structures that leave millions in Latin America and West Africa without viable legal alternatives. A defensive framing not only simplifies a complex reality, it deliberately displaces responsibility for it.
Repetition Without Resolution
Fifty-five years after Nixon’s declaration, the lesson available to any honest analyst remains the same. Militarised supply suppression does not reduce drug use, does not dismantle criminal networks, and does not produce security. It produces violence, displacement, corruption, and a revolving cast of new enemies to justify the next round of spending.
From Afghanistan to West Africa to the ports of Northern Europe, the evidence is consistent and damning. Alternative models, Portugal’s decriminalisation, the holistic development approaches recommended by the West Africa Commission on Drugs, the negotiated settlements pursued in Colombia, demonstrate that different paths exist.
They require a fundamental shift in perspective: treating the drug trade as a public health crisis with deep economic roots rather than a military target with a geographic address.
The Shield of the Americas does not represent that shift. It is the same chapter, retitled and re-costumed, held this time at a golf resort whose owner profits from every head of state who crosses the threshold.
Its significance lies less in what it will achieve, which is very little, than in what it reveals: the enduring political utility of a policy framework that has proven simultaneously resilient and ineffective, and the profound difficulty of moving beyond it when so many powerful interests depend on its continuation.
Abou the Author:
